Strategic Path Forward
The C-Scan system has received CE mark and approval from the Israeli Ministry of Health, the Medical Device Division (AMAR) for marketing in Israel.
Clinical Path in the U.S.
U.S. Pilot Study
Check-Cap has completed a pilot study in the U.S. to evaluate the safety, usability and subject compliance of the C-Scan system. The study was conducted at two sites, the New York University Grossman School of Medicine and Mayo Clinic.
*Due to sample size, the study was not designed to be powered for statistical significance
U.S. Pivotal Study
1.Prepless Colon Capsule Technology: New Research Examines This Less Invasive Approach to Colorectal Cancer Screening. Mayo Clinic Digestive Diseases Update. Gastroenterology and Hepatology. Vol 8, No.1, 2020.
The C-Scan System is not approved in the United States and is currently an investigational device there.
The system is approved in the E.U. and Israel but it is not available for sale in any jurisdiction.
This website is not intended to provide medical advice for patients or healthcare providers.